Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Martyna C. Popis
Observed name:
Martyna Popis
Institution:
University of Cambridge
Observed institutions:
Wellcome/MRC Cambridge Stem Cell Institute,
University of Cambridge,
MRC Centre for Regenerative Medicine,
MiNK Therapeutics (United States),
Wellcome Trust,
Medical Research Council
show all 6
ORCID:
0009-0005-6601-4784
Observed ORCID:
0009-0005-6601-4784
OpenAlex ID:
A5031142001
Aberrant methylation of tRNAs links cellular stress to neuro‐developmental disorders
2014
·
Sandra Blanco
, Sabine Dietmann
, et al.
·
The EMBO Journal
·
703
Stem cell function and stress response are controlled by protein synthesis
2016
·
Sandra Blanco
, Roberto Bandiera
, et al.
·
Nature
·
526
Cytosine-5 RNA methylation links protein synthesis to cell metabolism
2019
·
Nikoletta A. Gkatza
, Cecilia Castro
, et al.
·
PLoS Biology
·
143
PDF
Posttranscriptional methylation of transfer and ribosomal RNA in stress response pathways, cell differentiation, and cancer
2015
·
Martyna C. Popis
, Sandra Blanco
, et al.
·
Current Opinion in Oncology
·
65
PDF
Canonical Notch signaling controls the early thymic epithelial progenitor cell state and emergence of the medullary epithelial lineage in fetal thymus development
2020
·
Dong Liu
, Anastasia I. Kousa
, et al.
·
Development
·
39
PDF
CAR-iNKT cells: redefining the frontiers of cellular immunotherapy
2025
·
Magdalena Niedzielska
, Amy Chalmers
, et al.
·
Frontiers in Immunology
·
30
PDF
The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2025
·
Eleni Chantzoura
, Efrat Altman-Sharoni
, et al.
·
Cancer Immunology Research
·
7
Considerations for skin carcinogenesis experiments using inducible transgenic mouse models
2018
·
Martyna C. Popis
, Rebecca E. Wagner
, et al.
·
BMC Research Notes
·
6
PDF
753 AgenT-797 cell therapy can be combined with next-generation immune checkpoint inhibitors (ICI) and/or bi-specific engagers to improve anti-cancer response
2024
·
Martyna Popis
, Efrat Altman Sharoni
, et al.
·
Journal for ImmunoTherapy of Cancer
·
3
PDF
322 MiNK-413: a next generation armored allogenic BCMA CAR iNKT product
2022
·
Eleni Chantzoura
, Efrat Altman Sharoni
, et al.
·
Journal for ImmunoTherapy of Cancer
·
2
PDF
358 Development of an allogenic FAP CAR iNKT product to target tumor stroma and modulate the tumor microenvironment
2022
·
Xavier Michelet
, Martyna Popis
, et al.
·
Journal for ImmunoTherapy of Cancer
·
2
PDF
Non-invasive forecasting of skin cancer evolution through longitudinal hair sampling
2026
·
Stefania Del Prete
, Yoav Avi-Guy
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
Data from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026
·
Eleni Chantzoura
, Efrat Altman-Sharoni
, et al.
Figure S1 from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026
·
Eleni Chantzoura
, Efrat Altman-Sharoni
, et al.
Figure S6 from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026
·
Eleni Chantzoura
, Efrat Altman-Sharoni
, et al.
Table S3 from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026
·
Eleni Chantzoura
, Efrat Altman-Sharoni
, et al.
Figure S5 from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026
·
Eleni Chantzoura
, Efrat Altman-Sharoni
, et al.
Figure S8 from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026
·
Eleni Chantzoura
, Efrat Altman-Sharoni
, et al.
Figure S4 from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026
·
Eleni Chantzoura
, Efrat Altman-Sharoni
, et al.
Table S1 from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026
·
Eleni Chantzoura
, Efrat Altman-Sharoni
, et al.
Table S2 from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026
·
Eleni Chantzoura
, Efrat Altman-Sharoni
, et al.
Figure S2 from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026
·
Eleni Chantzoura
, Efrat Altman-Sharoni
, et al.
Figure S3 from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026
·
Eleni Chantzoura
, Efrat Altman-Sharoni
, et al.
Figure S7 from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity
2026
·
Eleni Chantzoura
, Efrat Altman-Sharoni
, et al.
135 Identification and characterization of an allogeneic iNKT-CAR targeting BCMA
2021
·
Xavier Michelet
, Eleni Chantzoura
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
Show more works
View as search
Works count:
25
Citation count:
1,525
H-index:
7
I10-index:
6
Year
Topic
Type